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Telomerase plays a crucial role in telomere maintenance in vivo. To understand telomerase
regulation, we have been characterizing components of the enzyme. To date several components
of the mammalian telomerase holoenzyme have been identified: the essential RNA component
(human telomerase RNA [hTR]), the catalytic subunit human telomerase reverse transcriptase
(hTERT), and telomerase-associated protein 1. Here we describe the identification of two new
proteins that interact with hTR: hStau and L22. Antisera against both proteins immunoprecipi-
tated hTR, hTERT, and telomerase activity from cell extracts, suggesting that the proteins are
associated with telomerase. Both proteins localized to the nucleolus and cytoplasm. Although
these proteins are associated with telomerase, we found no evidence of their association with each
other or with telomerase-associated protein 1. Both hStau and L22 are more abundant than TERT.
This, together with their localization, suggests that they may be associated with other ribonucle-
oprotein complexes in cells. We propose that these two hTR-associated proteins may play a role
in hTR processing, telomerase assembly, or localization in vivo.
INTRODUCTION
Telomerase is a specialized reverse transcriptase that is es-
sential for telomere maintenance. The telomerase ribonucle-
oprotein (RNP) uses an internal RNA template to synthesize
telomeric repeat sequences onto chromosome ends. Deletion
of the essential RNA component of telomerase leads to
progressive telomere shortening, chromosome instability,
and cell death in both yeast and mouse cells (Singer and
Gottschling, 1994; McEachern and Blackburn, 1996; Blasco et
al., 1997; Lee et al., 1998).
The telomerase enzyme is made up of an essential core as
well as several accessory proteins. The core telomerase en-
zyme consists of the RNA component (telomerase RNA
[TR]) and the catalytic subunit (telomerase reverse transcrip-
tase [TERT]). The structure of the RNA component is con-
served (Romero and Blackburn, 1991; Lingner et al., 1994) in
ciliates where the RNA is 150–200 nucleotides in length
(Greider and Blackburn, 1989). In mammalian cells the RNA
component is significantly larger, 390–450 nucleotides
(Blasco et al., 1995; Feng et al., 1995), and the structure is
highly conserved among vertebrates (Chen, Blasco, and
Greider, unpublished results). The catalytic TERT compo-
nent, first identified in the ciliate Euplotes (Lingner and Cech,
1996), has homologues in yeast (EST 2), human (hTERT),
and mouse (mTERT) (Harrington et al., 1997b; Lingner et al.,
1997b; Meyerson et al., 1997; Nakamura et al., 1997; Green-
berg et al., 1998; Martin-Rivera et al., 1998). TERT contains
sequence motifs similar to the conserved core of reverse
transcriptases, and mutation of the conserved essential as-
partate residues in the catalytic triad of reverse transcrip-
tases eliminates telomerase activity (Lingner et al., 1997b;
Weinrich et al., 1997). Minimal telomerase activity can be
reconstituted in an in vitro transcription/translation extract
using just the TERT and TR components (Weinrich et al.,
1997; Beattie et al., 1998), suggesting that these components
may be sufficient for catalysis.
In addition to the catalytic incorporation of nucleotides
onto telomeric 39 ends, telomerase has a number of addi-
tional properties including substrate recognition, processiv-
ity (Greider and Blackburn, 1987; Harrington and Greider,
1991; Collins and Greider, 1995), and primer cleavage (Col-
lins and Greider, 1993; Melek et al., 1996). Furthermore, in
mammalian cells telomerase activity is regulated in different
cell types as well as in different proliferative states. It is
possible that other proteins play important roles in these
processes. Two proteins, p80 and p95 from Tetrahymena,
copurify with telomerase (Collins et al., 1995) and are asso-
ciated with the enzyme in vivo (Gandhi and Collins, 1998).
The role of these two telomerase-associated proteins is not
yet clear. A homologue of p80, telomerase-associated pro-
tein 1 (TEP1), is associated with telomerase in human cells
(Harrington et al., 1997a; Nakayama et al., 1997). Purification‡ Corresponding author. E-mail address: cgreider@jhmi.edu.
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of the Euplotes telomerase led to the identification of a te-
lomerase-associated protein p43 in addition to TERT (p123)
(Lingner and Cech, 1996). This p43 protein has been identi-
fied as a homologue of the La protein in mammalian cells,
which binds the 39 end of many RNA polymerase III tran-
scripts (Lingner, Cech, and Wolin, personal communica-
tion). Recently, two chaperone proteins, p23 and Hsp90,
were shown to associate with human telomerase and facili-
tate RNP assembly (Holt et al., 1999). In yeast at least three
proteins, Est1p, Est3p, and Cdc13p, are associated with te-
lomerase (Lin and Zakian, 1995; Steiner et al., 1996) (Lund-
blad, personal communication). Although they are dispens-
able for telomerase activity assayed in vitro (Lingner et al.,
1997a), mutations in these proteins lead to telomere short-
ening in vivo and loss of cell viability (Lendvay et al., 1996).
Thus telomerase-associated proteins may play essential yet
undefined roles in telomerase biogenesis, assembly, and
regulation.
Both telomere length and telomerase activity have been
implicated in cellular senescence and cancer. During immor-
talization of mammalian cells in culture and in many human
tumors, telomerase is activated (Kim et al., 1994). Artificial
elongation of telomeres by ectopic hTERT expression in
primary human cells leads to the bypass of cellular senes-
cence, suggesting that telomerase expression and telomere
length play a direct role in cellular immortalization (Bodnar
et al., 1998; Vaziri and Benchimol, 1998). Recently it was
demonstrated that expression of TERT along with SV40 T
antigen and activated Ras are sufficient to transform primary
human cells (Hahn et al., 1999).
To explore fully the role of telomerase both in normal cells
and in tumor formation, it is important to characterize the
components of this complex enzyme. Biochemical evidence
indicates that human telomerase is .1000 kDa (Nakayama et
al., 1997; Schnapp et al., 1998), suggesting that it contains
numerous subunits in addition to hTERT and the RNA
component. We set out to identify proteins that interact
directly with the human telomerase RNA component. We
describe here the identification of two RNA-binding pro-
teins that interact with telomerase and may play a role in its
assembly, transport, or regulation.
MATERIALS AND METHODS
Three-Hybrid Screen
The three-hybrid system (SenGupta et al., 1996) was modified and
used to screen for human TR (hTR)-binding proteins. The new
reporter strain L40coatng was used. This strain is similar to the
L40coat strain described previously (SenGupta et al., 1996) but has a
nonaggregating form of coat protein instead of the wild-type MS2
coat. Nucleotides 64–222 of hTR were fused to the 59 end of the MS2
phage DNA to generate the pLS112 plasmid. To avoid transcrip-
tional termination by the RNA polymerase III, we changed four
nucleotides in hTR-MS2 RNA. Positions 82, 83, 102, and 103 of hTR
were changed to A, A, A, and C, respectively, to disrupt a string of
Us that was observed to cause transcriptional termination in initial
experiments. The fusion RNA of the expected size was detected on
Northern blots, indicating that it was transcribed and stable in yeast
cells (our unpublished results). The pLS112 plasmid was trans-
formed into the L40coatng strain along with cDNA–GAD fusion
libraries from HeLa, Jurkat, or human testes (provided by Dr. G.
Hannon and Dr. L. VanAelst, Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY, and Clontech, Palo Alto, CA). The positive
clones that grew in the presence of 5 mM 3-amino triazol and
stained positive for b-galactosidase were picked. These clones were
tested for reporter gene activation in the absence of RNA plasmids,
and only clones that activated the reporters in the presence of the
hTR-MS2 RNA, but not MS2 alone, were further characterized.
Positive clones from this screen were characterized further by DNA
sequencing and expression in mammalian cells as described in the
text.
Cloning Full-Length hStau
Rapid-amplification-of-cDNA-ends PCR was used to clone hStau.
By the use of a tagged human testis cDNA library (Marathon ready
human testis cDNA from Clontech) and gene-specific primers
within the cloned region, both the 59 and 39 half of the gene were
amplified by PCR according to the manufacturer’s protocols using
AP1- and hStau-specific primers 10-9 (CACCTCCAGCCTCTCTG-
GCAGGGGCTC) and 10-10 (GGCAAAGGAAAGACAAGACATG-
GCTGCG). Each half was subcloned into pCRScript SK1 (Strat-
agene, La Jolla, CA) and sequenced. The entire gene was then
reconstructed by cloning both halves together into the pCRScript
vector using a unique BamHI restriction site. The full-length cDNA
was then completely sequenced. The first in-frame methionine was
assigned as the first amino acid in the protein, although there is no
direct evidence of translation starting at this point. An AAUAAA
polyadenylation signal was found 1.3 kb downstream of the stop
codon for the longest predicted ORF. By the use of this assignment,
the calculated molecular weight of the hStau protein is 55 kDa. This
agrees well with the size of the protein identified on Western blots
(see Figure 2).
Generation of Antibodies
For L22, a synthetic peptide was generated that corresponds to the
N-terminal region of the protein (CMAPVKKLVVKGG). The pep-
tide was coupled to KLH and used to generate antisera in rabbits.
To generate antibodies to hStau, we subcloned the partial cDNA
that was obtained in the initial three-hybrid library into the bacterial
expression vector to generate an N-terminal fusion of GST with the
C-terminal 448 amino acids of hStau. The fusion protein GST-hStau
was overexpressed in bacteria, purified over a glutathione column
(Pharmacia, Piscataway, NJ), and used to generate antibodies in
rabbits (Covance Research Products, Denver, PA).
Antisera from the rabbits were initially screened for protein or
peptide binding using an ELISA assay. Positive antisera were then
tested for specificity on Westerns and by immunoprecipitation. The
antisera against L22 recognized a 15-kDa protein as expected both in
cell lysates and in immunoprecipitations. Antibodies directed




Western analysis, immunoprecipitation, and immunofluorescence
were performed according to the procedures of Harlow and Lane
(1988). Human 293 cell extracts were made using either Nonidet
P-40 (up to 1%) buffer (Harlow and Lane, 1988) or hypotonic buffer
(Counter et al., 1992) and used for Western and immunoprecipita-
tion (IP) analysis. Some hStau immunoprecipitations were per-
formed using hStau serum that was coupled to CNBr-activated
Sepharose beads to avoid IgG bands that have a molecular weight
similar to that of hStau in the subsequent Western analysis.
Immunodepletion was done by sequential immunoprecipitation.
After four rounds of immunoprecipitation, the supernatant was
Western blotted, and the hStau level was quantitated relative to the
level in the starting extract.
In L22 or nucleolin immunofluorescence experiments, fixed cells
were stained either with L22 or nucleolin (C23; Santa Cruz Biotech-
nology, Santa Cruz, CA) antiserum. After staining with Texas Red–
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or indocarbocyanine-conjugated secondary antibodies, cells were
mounted with Vectashield mounting media (Vector Laboratories,
Burlingame, CA) (with or without DAPI) and viewed using a Zeiss
(Thornwood, NJ) fluorescence microscope.
Green Fluorescent Protein (GFP) Fusion Proteins
To determine the subcellular localization of the hStau protein, we
fused hStau cDNA to GFP in pEGFP-C1 (Clontech), and the fusion
protein was expressed in 293 cells. The expression of fusion protein
was confirmed by Western blot analysis. Green fluorescence images
were obtained using a Zeiss fluorescence microscope after 48 h of
transfection.
Reverse Transcriptase (RT)-PCR
RT-PCR was used to quantitate RNAs in the supernatant and pellet
of immunoprecipitation reactions. RNAs were prepared from both
supernatant and pellet fractions by phenol and chloroform extrac-
tion and ethanol precipitation. The same amount of total RNA was
then used for each reaction in a first-strand cDNA synthesis reaction
using random hexamer primers and Superscript II reverse transcrip-
tase (Life Technologies, Gaithersburg, MD). The cDNAs were then
PCR amplified using hTR-, U2-, U3-, 7SL-, or RNase P-specific primers.
The primers used are as follows: hTR, GCCTGGGAGGGGTGGTG-
GCCATTTTTTG and GTTTGCTCTAGAATGAACGGTGGAAG;
U2, ATCGCTTCTCGGCCTTTT and GGGTGCACCGTTCCT-
GGGA; U3, GACTATACTTTCAGGGATCATTTC and CCACTCA-
GACCGCGTTCTCTC; 7SL, GTGCCTGTAGTCCCAGCTAC and
GAGACGGGGTCTCGCTATG; and RNase P, GGAAGGTCT-
GAGACTAG and ATCTCCTGCCCAGTCTG. The number of PCR
cycles was adjusted for different cDNA amplifications so that PCR
was in the linear range. To control for genomic DNA contamination,
cDNA synthesis reactions were also done in the absence of the RT.
No signal was generated in the absence of RT. PCR products were
separated on a 6% native polyacrylamide gel, dried, and exposed.
Signal intensity was quantified on a STORM PhosphorImager sys-
tem (Molecular Dynamics, Sunnyvale, CA).
Telomerase Assay
Cell extracts, immunoprecipitation supernatants, or pellet fractions
were assayed in a two-step telomerase assay (telomeric repeat am-
plification protocol [TRAP]) similar to that described previously
(Autexier et al., 1996). This two-step procedure uses a limited num-
ber of PCR cycles for amplification of the telomerase products so
that the signal will be in the linear range. Thus relative signal
intensities reflect relative activity in a semiquantitative manner.
Negative controls that had either no extract or RNase-treated sam-
ples were used. An internal standard for product amplification in




To identify proteins that bind to the hTR, we used a modi-
fied three-hybrid system (SenGupta et al., 1996). Nucleotides
64–222 of the 451 nucleotides of human telomerase RNA
were fused to the MS2 phage RNA and expressed in yeast
behind the RNase P promoter. This region of the RNA can
form a highly conserved stem–loop structure (Chen, Blasco,
and Greider, unpublished results) and is required for activ-
ity in in vitro reconstitution assays (Autexier et al., 1996;
Beattie et al., 1998). Three different human cDNA–GAD fu-
sion libraries (from HeLa, Jurkat, and human testes) were
screened for proteins that interact with hTR (see MATERI-
ALS AND METHODS). Positives that interacted with hTR-
MS2, but not MS2 alone, were identified, and the partial
cDNA clones were tagged with the hemagglutinin (HA)
epitope. These tagged clones were used to transfect 293 cells
to test whether they would interact with hTR in human cells.
Two proteins were identified that showed specific associa-
tion with hTR after immunoprecipitation with HA antibody
(our unpublished results). They are ribosomal-associated
protein L22, which was shown previously to bind Epstein-
Barr virus (EBV)-encoded RNA (EBER) in EBV-infected cells
(Toczyski et al., 1994), and a new protein that we initially
called telomerase-associated protein 3 (TEP3). This protein
was identified recently by others and given the name hStau
(Marion et al., 1999; Wickham et al., 1999).
We cloned the full-length cDNA of hStau using rapid-
amplification-of-cDNA-ends PCR from testis cDNA. The
cDNA encodes a 496-amino-acid open reading frame with a
1.3-kb-long 39-untranslated region. Our clone corresponds to
the most abundant isoform of the several hStau isoforms
described by Wickham et al. (1999). A motif search revealed
several regions of the protein that contain significant homol-
ogy to double-stranded RNA-binding domains that were
originally identified in the Drosophila Staufen protein (Figure
1). hStau protein, like other double-stranded RNA-binding
domain proteins, has two full-length and two short RNA-
binding domains. The organization of the domains in hStau
is similar to that of Staufen although hStau is shorter in
length overall (Figure 1A). Furthermore the sequence simi-
larity is limited to the RNA-binding domains; the fact that
other regions of the proteins are not conserved suggests that
although hStau uses Staufen-related motifs to bind to RNA,
it may have a different function than does Staufen.
Interaction with hTR In Vivo
To examine further the interaction of L22 and hStau with
hTR, we generated antibodies to both proteins and tested the
ability of the antibodies to precipitate hTR. For L22, anti-
peptide antibodies were made, whereas for hStau, antibod-
ies to a recombinant GST fusion protein were generated (see
MATERIALS AND METHODS). IP and Western blotting
showed that these antibodies were specific for the appropri-
ate proteins (Figure 2, A and B). Anti-hStau antibody recog-
nized a major 55-kDa protein on Western blots of both cell
lysates and immunoprecipitation reactions, consistent with
its predicted molecular weight (see Figures 2A and 6A).
Other isoforms of the protein were also detected, and they
are likely to represent the other isoforms of the hStau protein
containing different N termini (Wickham et al., 1999). The
L22 antibody precipitated a 15-kDa protein that was not
seen using preimmune serum or when the peptide was
preincubated with the antibody before the IP (Figure 2B).
To examine whether L22 and hStau interact with hTR in
vivo, immunoprecipitations were performed on 293 cell ly-
sates. The antibodies against L22 and hStau described above
were used as well as several unrelated antibodies as con-
trols. Using PCR, we measured the amount of hTR in the
supernatant and pellet fraction of the immunoprecipitation
reactions (Figure 2C). hTR was enriched in the pellets of the
anti-hStau and anti-L22 immunoprecipitation reactions rel-
ative to reactions using the preimmune sera or two unre-
lated antibodies, anti-GST and anti-chymotrypsin. In addi-
tion when the anti-L22 antibody was preincubated with L22
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peptide, a lower fraction of hTR was precipitated, indicating
that the immunoprecipitation is relatively specific (Figure
2C). To quantify the level of enrichment, we repeated this
experiment several times, and the average enrichments are
shown in Figure 2D. As a second control for specificity of the
interaction with hTR, we tested whether four abundant
small RNAs (U2, U3, 7SL, and RNase P RNA) were also
precipitated by our antibodies (Figure 2, C and D). Most of
these RNAs were not detected at significant levels in the
immunoprecipitation pellets, although some U2 and U3
RNA was detected in the pellet fraction of the anti-hStau
precipitation. The precipitation of U2 and U3 could be
caused by the high copy number of these RNAs (2–5 3 105
per cell) (Baserga and Steitz, 1993) compared with the hTR
that is only present at 500 copies per cell (Avilion, 1995).
Alternatively, hStau may have some affinity for U2 and U3
RNA.
As a final control for specificity, we tested whether hTR
was precipitated by antibodies directed against other abun-
dant RNA-binding proteins, such as Sm (Baserga and Steitz,
1993) and SF2 (Krainer et al., 1991) proteins. Anti-Sm and
anti-SF2 antibodies precipitated these two proteins, respec-
tively (Figure 3, B and C). The level of hTR brought down by
these antibodies was significantly less than that brought
down by antibodies to hStau (Figure 3A). Together the im-
munoprecipitation experiments suggest that hStau and L22
specifically associate with hTR in vivo.
To estimate how much hTR is associated with hStau or
L22, we immunodepleted hStau or L22 from human 293 cell
extracts and assayed for the presence of hTR by RT-PCR.
Figure 1. Structural alignment and sequence comparison of domains in hStau and other double-stranded RNA (dsRNA)-binding proteins.
(A) Structure of hStau and other proteins that contain double-stranded RNA-binding domains. Full-length dsRNA-binding domains are
indicated by gray boxes, and short domains are indicated by white boxes. The numbers under the domains in hStau and Staufen correspond
to the sequences listed in B. (B) Sequence homology between double-stranded RNA-binding domains of human Staufen and Drosophila
Staufen (STAU). Top and Middle, alignment of the full-length domains. Bottom, alignment of the short domains. Identical residues are
shaded; * symbols indicate the residues that are highly conserved in most of the double-stranded RNA-binding domains containing proteins
(St. Johnston et al., 1992) (note that not all sequences are shown). Sequences used in the alignment are as follows: hStau-1, aa 59–79; hStau-2,
aa 100–172; hStau-3, aa 202–275; hStau-4, aa 452–472; STAU-1, aa 308–380; STAU-2, aa 490–559; STAU-3, aa 575–647; STAU-4, aa 708–782;
and STAU-5, aa 948-1020.
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Figure 2. hStau and L22 interact with hTR. (A) hStau antibody specificity. Western blot analysis on a 293 cell extract (lane 1) and hStau
immunoprecipitates (lane 2) using anti-hStau antibody shows the 55-kDa hStau protein. The relative mobility of molecular weight markers
(in kilodaltons) is indicated on the left. (B) L22 antibody specificity. Western blot analysis on 293 cell extracts (lane 1) and L22 immunopre-
cipitates (lanes 2–4) is shown. Lane 2, precipitation using preimmune serum (pre); lane 3, precipitation using anti-L22 serum; and lane 4,
preincubation of L22 peptide (pep) with anti-L22 serum before immunoprecipitation. The relative mobility of molecular weight markers (in
kilodaltons) is indicated on the left. The arrow indicates the L22 band (15 kDa). The IgG heavy and light chains (arrowheads) are also
indicated. (C) RT-PCR analysis of RNAs in the supernatant (Sup; lanes 1–7) and pellet (lanes 8–14) fractions of hStau and L22 immunopre-
cipitation reactions. Lanes 1 and 8, hStau precipitation using preimmune serum; lanes 2 and 9, precipitation using anti-hStau antibody; lanes
3 and 10, precipitation using anti-GST antibody; lanes 4 and 11, precipitation using anti-chymotrypsin (-chym.) antibody; lanes 5 and 12,
precipitation using L22 preimmune serum; lanes 6 and 13, precipitation using anti-L22 antibody; and lanes 7 and 14, precipitation using
anti-L22 antibody preincubated with L22 peptide. The RNAs amplified in the fractions are indicated on the left (hTR, U2, U3, 7SL, and RNase
P). (D) Quantitation of RNAs precipitated in C. The RNA precipitated is expressed as a fraction of the total signal intensity obtained in both
the pellet and supernatant. RNAs assayed are indicated on the left, and antibodies used are indicated on the bottom. L221pep, L22 antibodies
preincubated with the L22 peptide before immunoprecipitation. a.u., arbitrary units.
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Upon removal of ;90% of the hStau protein from extracts,
there was a 15–50% reduction of hTR (our unpublished
results), whereas for L22, only ;10% of hTR was associated
with the protein (our unpublished results). These results
suggest that, although hTR is associated with hStau and L22,
not all of the hTR in the cell is associated with hStau or L22.
hStau and L22 Interact with Telomerase
To determine whether hStau or L22 is associated with te-
lomerase, we assayed telomerase activity in anti-hStau and
anti-L22 immunoprecipitates. Immunoprecipitation reac-
tions were performed using either anti-hStau, anti-L22, pre-
immune serum, or an unrelated anti-GST antibody. The
pellet fractions were assayed for telomerase activity by the
TRAP assay. Telomerase activity was specifically immuno-
precipitated with both the anti-hStau and anti-L22 antisera.
Little activity was seen in immunoprecipitations with pre-
immune sera, and none was seen with the anti-GST antibody
(Figure 4A). Preincubation with the L22 peptide significantly
reduced the level of telomerase activity precipitated in the
anti-L22 pellet fractions. Thus both hStau and L22 are asso-
ciated with telomerase activity.
Telomerase activity requires the catalytic subunit hTERT
(Nakamura et al., 1997). We tested whether the hTERT pro-
tein was present in the immunoprecipitation reactions with
antibodies to hStau and L22, but we failed to detect endog-
enous hTERT on Westerns (our unpublished results). This
result is similar to that found using antibodies to the telom-
erase-associated protein TEP1 (Harrington et al., 1997b) and
is likely caused by the low levels of endogenous hTERT in
cells and/or by the low affinity of the hTERT antibody. Thus
to examine the association of hStau and L22 with hTERT, we
transfected 293 cells with a cDNA that expresses hTERT
tagged with the HA epitope (Counter et al., 1998). Cell
extracts were made, and antibodies directed against hStau
and L22 were used in immunoprecipitation reactions. West-
ern analysis of the pellet fraction using anti-HA antibodies
showed that hTERT was precipitated by both anti-hStau and
anti-L22 antisera but not by preimmune sera (Figure 4B).
These results indicate that hStau and L22 protein associate
with hTERT.
Subcellular Localization of hStau
To determine the subcellular localization of the hStau pro-
tein, we fused hStau to GFP and transiently expressed the
fusion protein in 293 cells. hStau localized to both nucleoli
and cytoplasm (Figure 5). We assayed the location of nucleo-
lin and L22 as a control for nucleolar staining. The hStau
nucleolar localization was coincident with the staining by an
anti-nucleolin or anti-L22 antibody (Figure 5). L22 has been
shown previously to localize to both nucleoli and cytoplasm
(Toczyski et al., 1994). Recent reports have suggested that the
hStau protein localizes to the rough endoplasmic reticulum
(Marion et al., 1999; Wickham et al., 1999), although nucleolar
staining was also reported by one group (Marion et al., 1999).
The hStau fluorescence observed was specific because it was
not observed either when cells were mock treated or when
GFP alone was expressed. Thus hStau is present in nucleoli
where the RNA component hTR also localizes (Mitchell et
al., 1999; Narayanan et al., 1999).
Interactions among Telomerase-associated Proteins
TEP1 was identified as a homologue of the Tetrahymena p80
telomerase component and was shown to interact with
hTERT in vivo (Harrington et al., 1997a). To test whether
hStau or L22 interact with each other or with TEP1, we
performed a series of coimmunoprecipitation reactions. An-
tibodies directed against hStau immunoprecipitated hStau,
but L22 was not detectable in the pellets. Similarly, antibod-
ies directed against L22 brought down L22, but hStau was
not detectable in the pellets (Figure 6A). A faint band mi-
grating slightly faster than hStau was seen in both the hStau
preimmune and L22 immunoprecipitation reactions. Be-
cause this band is seen at similar levels in the preimmune
sera and the specific L22 immunoprecipitation, it likely rep-
resents a nonspecific association. These results suggest that
hStau and L22 do not interact with each other.
Figure 3. Anti-Sm and anti-SF2 antibodies do not precipitate hTR.
(A) Quantitation of hTR precipitated as described in Figure 2D.
Antibodies used are indicated on the bottom. (B) Western blot
analysis on 293 cell extracts (lane 2) and an Sm immunoprecipitate
(lane 1). The arrow indicates Sm proteins (28–29 kDa) recognized by
mAb Y12. IgG bands (arrowheads) are also indicated on the right.
(C) Western blot analysis on 293 cell extracts (lane 2) and SF2
immunoprecipitates (lane 1). The arrow indicates the SF2 protein (33
kDa). IgG bands (arrowheads) are also indicated on the right.
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To examine the interaction of hStau and L22 with TEP1,
we used 293 cells transfected with expression plasmids for
myc-tagged TEP1. In these transfected cells, anti-hStau an-
tibody immunoprecipitated hStau, but TEP1 was not de-
tected by Western analysis probing for the myc-epitope tag
(Figure 6B). Similarly, anti-L22 antibody immunoprecipi-
tated L22 but not myc-tagged TEP1 from myc-TEP1–ex-
pressed cells (Figure 6C). However, as described previously
(Harrington et al., 1997b), myc-TEP1 protein was coprecipi-
tated when overexpressed hTERT was immunoprecipitated
(our unpublished results), indicating that TEP1 protein as-
sociates with telomerase. Thus, these results suggest that
TEP1, hStau, and L22 are not associated with each other, yet
they are individually associated with hTR and hTERT.
DISCUSSION
We have identified two new hTR-binding proteins, L22 and
hStau. Although both of these proteins are associated with
hTR in vivo, they appear not to associate with each other.
The nucleolar localization suggests that these proteins might
be involved with various stages of RNA processing or RNP
assembly.
hStau Is an RNA-binding Protein
hStau is a double-stranded RNA-binding protein that asso-
ciates with hTR in vivo. hStau belongs to a family of proteins
that contains multiple double-stranded RNA-binding do-
mains (St. Johnston et al., 1992). The structural organization
of the domains as well as sequences within these domains is
most similar to that of the Drosophila Staufen protein (St.
Johnston et al., 1991). However sequences outside of the
dsRNA-binding region are not conserved between hStau
and Staufen, suggesting that although the RNA-binding
function may be conserved, other functions may differ be-
tween these proteins. In Drosophila, the Staufen protein spe-
cifically binds a structure in the bicoid and oskar mRNA and
is necessary for the proper localization of these RNAs to the
anterior and posterior of the oocyte, respectively (St.
Johnston et al., 1991). Staufen protein also binds to prospero
mRNA and contributes to its localization to neuroblasts
during development (Broadus et al., 1998). In vitro, Staufen
binds directly to bicoid mRNA (St. Johnston et al., 1992).
Although the binding of Staufen in vivo is specific, a 76-
amino-acid recombinant fragment containing the double-
stranded RNA-binding domain of Staufen will bind to many
RNAs in vitro that contain extensive secondary structure but
not unstructured RNAs (St. Johnston et al., 1992). Upon
injection of various RNAs into Drosophila embryos, the
Staufen protein binds the bicoid 39-untranslated region
strongly but has little affinity for other structured RNAs like
VA1 or poly (rI/rC) (Ferrandon et al., 1994). Recently hStau
was shown to bind bicoid RNA in vitro (Marion et al., 1999;
Wickham et al., 1999). We found that in vivo hStau binds
hTR and to some extent U2 and U3 RNA. In contrast there
was no detectable association of hStau with 7SL or RNase P
RNAs in vivo (Figure 2C). This in vivo binding specificity
may be achieved in part via the specific conformation of the
RNA and/or the association with other proteins in an RNP
complex.
Figure 4. hStau and L22 interact with telomerase and hTERT. (A) hStau
and L22 associate with telomerase activity in 293 cells. Telomerase assays
(modified TRAP, see MATERIALS AND METHODS) were performed on
a 293 extract (assayed at 5 mg of protein; lane1) and immunoprecipitation
pellets (lanes 2–13) from immunoprecipitations with various antibodies.
The antibodies used are indicated at the top of the gel. Lanes 2 and 3,
precipitation using hStau preimmune serum; lanes 4 and 5, precipitation
using anti-hStau antibody; lanes 6 and 7, precipitation using anti-GST
antibody; lanes 8 and 9, precipitation using L22 preimmune serum; lanes
10 and 11, precipitation using anti-L22 antibody; and lanes 12 and 13,
precipitation using anti-L22 antibody preincubated with L22 peptides.
Samples in lanes 3, 5, 7, 9, 11, and 13 were pretreated with RNase (1)
before the telomerase reactions. (B) hStau and L22 interact with hTERT.
Western blot analysis using anti-HA (top), anti-hStau (middle), or anti-L22
(bottom) antibody on cell lysates (lanes 1 and 2) or various immunopre-
cipitation pellets (lanes 3–8) is shown. Extracts used are a mock-trans-
fected 293 extract (lanes 1, 3, and 6) and an hTERT-HA–transfected cell
extract (lanes 2, 4, 5, 7, and 8). The antibodies used in immunoprecipitation
reactions were the following: lanes 3 and 5, precipitation using anti-L22;
lane 4, precipitation using L22 preimmune serum; lanes 6 and 8, precipi-
tation using anti-hStau; and lane 7, precipitation using hStau preimmune
serum. The relative mobility of molecular weight markers (in kilodaltons)
is indicated on the left. The identity of various bands is indicated by
arrows.
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L22 Is an RNA-binding Protein
L22, which associates with hTR, is an RNA-binding protein.
L22 was described previously as a ribosomal-associated pro-
tein. However, although it is localized in the nucleolus and
purifies with ribosomes, little is known about its role in
ribosome function (Lavergne et al., 1987; Toczyski et al.,
1994). The binding site for L22 was determined previously
by RNA selection to include a stem–loop structure with
three conserved nucleotides at the top of the stem (Dobbel-
stein and Shenk, 1995). A similar stem–loop structure con-
Figure 5. Subcellular localization of the hStau and the
L22 protein. (A) Green fluorescence of GFP-hStau and
nucleolin immunofluorescence of 293 cells expressing the
GFP-hStau fusion. Cells were stained with DAPI (blue,
top), green fluorescence (green, second from top), and
anti-nucleolin (red, second from bottom), and images
were merged (bottom). (B) Green fluorescence of GFP-
hStau and L22 immunofluorescence of 293 cells express-
ing the GFP-hStau fusion. Cells were stained with DAPI
(blue, top) and L22 antiserum (red, bottom) and pro-
cessed for a green fluorescence image (green, middle).
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taining the consensus L22-binding site is present in the hTR
fragment that was used in the three-hybrid screen (Chen,
Blasco, and Greider, unpublished results). This suggests that
L22 may bind directly to hTR via this stem–loop structure.
L22 also binds EBER1 in EBV-infected human B lympho-
cytes (Toczyski et al., 1994). Upon infection with EBV, L22
translocates to the nucleoplasm and associates with EBER1
(Toczyski et al., 1994). It thus will be interesting to determine
whether the interaction between L22 and hTR is altered by
EBV infection.
The Role of RNA-binding Proteins in Telomerase
Complexes
RNA-binding proteins may be involved in the maturation,
localization, and assembly of RNPs. hStau and L22 may
Figure 6. Interaction between telomerase-associated proteins. (A)
hStau and L22 do not interact with each other. A 293 cell lysate was
immunoprecipitated with hStau preimmune serum (lane 2), hStau
antibody (lane 3), L22 preimmune serum (lane 4), or L22 antibody
(lane 5). The pellet fractions were analyzed by Western hybridiza-
tion probed with either hStau antibody (top) or L22 antibody (bot-
tom). (B) hStau and myc-TEP1 do not interact. 293 cells were either
mock transfected (lanes 1, 3, and 4) or transfected with the myc-
TEP1 construct (lanes 2, 5, and 6). Cell lysates were either run
directly on a Western (lanes 1 and 2) or immunoprecipitated with
either hStau preimmune serum (lanes 3 and 5) or hStau antibody
(lanes 4 and 6). The Western was probed with anti-myc antibody
(top) or hStau antibody (bottom). (C) L22 and myc-TEP1 do not
interact. 293 cells were either mock transfected (lanes 1 and 3) or
transfected with the myc-TEP1 construct (lanes 2, 4, and 5), and cell
lysates were either run directly on a Western (lanes 1 and 2) or
immunoprecipitated with either hStau preimmune serum (lane 4) or
L22 antibody (lanes 3 and 5). The Western was probed with anti-
myc antibody (top) or L22 antibody (bottom). The relative mobility
of molecular weight markers (in kilodaltons) is indicated on the left
in A–C.
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mediate these functions for the telomerase RNP. L22 was
reported previously to localize to nucleoli (Toczyski et al.,
1994). We found that hStau also localizes to nucleoli. Inter-
estingly, recent studies have shown that hTR contains a
conserved box H/ACA sno-RNA motif and localizes to nu-
cleoli (Mitchell et al., 1999; Narayanan et al., 1999). Because
many RNA-processing activities as well as RNP assembly
are performed in the nucleolus (Pederson, 1998), L22 and
hStau may play a role in hTR localization, processing, and
telomerase RNP assembly. The p43 protein from Euplotes,
which copurifies with TERT, is also an RNA-binding protein
similar to the La antigen (Lingner, Cech, and Wolin, per-
sonal communication). The La antigen is involved in the
stability of RNA polymerase III transcripts as well as their
maturation and assembly into functional RNPs (Wolin and
Matera, 1999). A variety of different RNA-binding proteins
may associate with hTR at different stages of its biogenesis
and contribute to the transport, localization, and assembly of
telomerase.
Although hStau and L22 are individually associated with
hTERT, they fail to interact with each other. This suggests
that they may be associated with telomerase at distinct
stages of biogenesis. In agreement with this, we found that
only ;15–50% of hTR is associated with hStau at steady
state in vivo. hTR is thus likely to be present in other
complexes in addition to those with hStau and L22.
Multiprotein Complexes and RNP Biogenesis
Another common feature shared among TEP1, hStau, and
L22 is that they participate in other cellular RNP complexes
in addition to telomerase association. TEP1 is associated
with the vault RNP (Kickhoefer et al., 1999). Vaults are
evolutionary-conserved, large cytoplasmic RNPs with a pos-
sible role in nucleocytoplasmic transport (Chugani et al.,
1993; Kickhoefer et al., 1996). hStau mRNA is expressed at
similar levels in a wide variety of human tissues; the protein
level however varies significantly in different tissues, sug-
gesting possible translational regulation (our unpublished
results). The hStau protein is localized to the rough endo-
plasmic reticulum and the nucleolus (Marion et al., 1999;
Wickham et al., 1999) (and this report). L22 is localized to
the nucleolus and copurifies with ribosomes, in addition
to its binding to EBER RNAs in EBV-positive cells (Toc-
zyski et al., 1994). Such sharing of components has been
seen in several multiprotein complexes. For example, p21
interacts with cyclin-dependent kinase (CDK) (Xiong et
al., 1993) to inhibit its activity and also binds PCNA to
inhibit PCNA-dependent DNA replication (Warbrick et
al., 1995; Gulbis et al., 1996). The p21-binding site for CDK
and PCNA appears to be separable (Chen et al., 1995).
Similarly, the coactivator p300/CBP (histone acetyltrans-
ferase) is found in a large number of transcription com-
plexes, including the nuclear receptors (Korzus et al.,
1998) cAMP response element– binding protein (Chrivia et
al., 1993; Kwok et al., 1994) and STAT-1 (Darnell, 1997).
The high abundance of TEP1, L22, and hStau is consistent
with their playing a role in a variety of multisubunit
complexes and their role in RNA processing and RNP
assembly.
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